Hanover Insurance Group Inc-The

CEO John C. Roche’s disciplined 10b5‑1 plan buys and sells at THG show long‑term confidence and alignment with shareholders, hinting at steady growth.

Roche John C’s recent Rule 10b5‑1 trades at Hanover reveal disciplined insider buying and selling, signaling confidence in the insurer’s long‑term growth.

Denise Lowsley’s insider buying at Hanover Insurance shows long‑term confidence in the company’s expansion, hinting at upside amid modest valuation.

Lee Willard’s recent 1,000‑share sale at $183.93 shows routine insider liquidations; investors see a neutral signal for Hanover’s stable value and future upside.

Insider buying signals at Hanover: Execs pile up shares near a 52‑week high before Q1 earnings, hinting at confidence and potential upside if results beat expectations.

Jeffrey Farber’s recent insider buys signal confidence in Hanover’s value, steady dividends, and solid growth—insider buying suggests the stock is undervalued and a great income investment.

Investor insight: Lavey’s massive February 2026 buy‑and‑sell at Hanover reflects portfolio rebalancing, not a signal of weakness—solid earnings and long‑term stewardship remain intact.